3 Results for
- View:
- Only Recruiting Trials
-
All Trials
Study Title | Principal Investigator |
---|---|
VX-770 Expanded Access Program (EAP)
Approved for marketing | Cystic Fibrosis | Site Unknown
|
View Research Profile |
A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Completed | Cystic Fibrosis | Multisite
|
View Research Profile |
A 24-week, Open-label, Parallel-group, Interventional Phase IV Study Comparing Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles for the Treatment of Pulmonary Pseudomonas Aeruginosa in Patients With Cystic Fibrosis
Terminated | Cystic Fibrosis | Multisite
|